Timothy Freels, Ph.D. - Publications
Affiliations: | Neurobiology | University of Massachusetts Medical School, Worcester, MA, United States |
Year | Citation | Score | |||
---|---|---|---|---|---|
2024 | Honeywell KM, Freels TG, McWain MA, Chaffin AS, Nolen HG, Sable HJ, Lester DB. Indirect and direct cannabinoid agonists differentially affect mesolimbic dopamine release and related behaviors. Behavioral Neuroscience. 138: 108-124. PMID 38661670 DOI: 10.1037/bne0000582 | 0.63 | |||
2023 | Molas S, Zhao-Shea R, Freels TG, Tapper AR. Viral Tracing Confirms Paranigral Ventral Tegmental Area Dopaminergic Inputs to the Interpeduncular Nucleus Where Dopamine Release Encodes Motivated Exploration. Eneuro. 10. PMID 36599671 DOI: 10.1523/ENEURO.0282-22.2022 | 0.423 | |||
2021 | Gabriel DBK, Liley AE, Freels TG, Simon NW. Dopamine receptors regulate preference between high-effort and high-risk rewards. Psychopharmacology. PMID 33410986 DOI: 10.1007/s00213-020-05745-z | 0.441 | |||
2019 | Freels TG, Gabriel DBK, Lester DB, Simon NW. Risky decision-making predicts dopamine release dynamics in nucleus accumbens shell. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31546248 DOI: 10.1038/S41386-019-0527-0 | 0.591 | |||
2019 | Estes MK, Freels TG, Prater WT, Lester DB. Systemic oxytocin administration alters mesolimbic dopamine release in mice. Neuroscience. PMID 30981861 DOI: 10.1016/j.neuroscience.2019.04.006 | 0.568 | |||
2019 | Freels TG, Lester DB, Cook MN. Arachidonoyl serotonin (AA-5-HT) modulates general fear-like behavior and inhibits mesolimbic dopamine release. Behavioural Brain Research. 362: 140-151. PMID 30639609 DOI: 10.1016/j.bbr.2019.01.010 | 0.548 | |||
2018 | Holloway ZR, Freels TG, Comstock JF, Nolen HG, Sable HJ, Lester DB. Comparing phasic dopamine dynamics in the striatum, nucleus accumbens, amygdala, and medial prefrontal cortex. Synapse (New York, N.Y.). e22074. PMID 30317673 DOI: 10.1002/syn.22074 | 0.627 | |||
Show low-probability matches. |